Please ensure Javascript is enabled for purposes of website accessibility
Is Alzheimer's Breakthrough Drug Finally Coming?
Bill McEwen updated website photo 2024
By Bill McEwen, News Director
Published 7 years ago on
July 26, 2018

Share

CHICAGO — Hopes are rising again for a drug to alter the course of Alzheimer’s disease after decades of failures. An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study, and it removed much of the sticky plaque gumming up their brains, the drug’s makers said Wednesday.
The results have been highly anticipated and have sent the stock of the two companies involved soaring in recent weeks.
The drug from Eisai and Biogen did not meet its main goal in a study of 856 participants, so overall, it was considered a flop. But company officials said that 161 people who got the highest dose every two weeks for 18 months did significantly better than 245 people who were given a dummy treatment.
There are lots of caveats about the work, which was led by company scientists rather than academic researchers and not reviewed by outside experts. The study also was too small to be definitive and the results need to be confirmed with more work, dementia experts said. But they welcomed any glimmer of success after multiple failures.

Cautious Optimism About Drug

“We’re cautiously optimistic,” said Maria Carrillo, chief science officer of the Alzheimer’s Association, whose international conference in Chicago featured the results.
“A 30 percent slowing of decline is something I would want my family member to have,” and the drug’s ability to clear the brain plaques “looks pretty amazing,” she said.
About 50 million people worldwide have dementia, and Alzheimer’s is the most common type. There is no cure— current medicines just ease symptoms. Some previous efforts to develop a drug to slow the disease may have been tried too late, after much damage had already occurred. The new drug aimed sooner, in people with early Alzheimer’s, and the drug works at an earlier step in the formation of the sticky brain plaques.
Study participants were given one of five doses of BAN2401 or a dummy treatment via IV. After one year, the companies said the drug didn’t meet statistical goals. But after 18 months, they saw a benefit in the highest dose group.

New Measurement of Mental Decline

What makes it tricky, though, is that they used a new way to measure mental decline, a scale that combines parts of three other widely used tests. This is the first study to use that measure, and it’s unclear how much of a difference a 30 percent slowing of decline makes — whether it allows someone to continue to bathe or feed himself, for instance.
“It’s intriguing, but these are designs we’re not used to seeing,” and it will require more study for doctors to feel comfortable with this as a measure of success, said one independent expert, Dr. Julie Schneider of Rush University Medical Center in Chicago.
On one traditional measure of thinking skills, those at the highest dose declined 47 percent less than people given a dummy treatment.

High Doses Remove Brain Plaques

Brain scans added evidence that the drug might be effective. All participants had signs of the sticky plaques that are the hallmark of Alzheimer’s at the start of the study, but 81 percent of people on the highest dose saw all signs of them disappear after 18 months, an Eisai official said.
Side effects leading to discontinuation of treatment occurred in 19 percent of those on the high dose and 6 percent of the dummy treatment group. Cases of brain swelling, which have been seen in other treatments targeting the plaques in the brain, occurred in two people in the placebo group and 16 of those in the high dose group.
Other dementia experts were encouraged.
“That’s a very hopeful outcome. It means we may be on the right track,” said another scientist with no role in the work, Dr. Stephen Salloway, neurology chief at Brown University in Providence, Rhode Island.

Not a Cure

Dr. Reisa Sperling, a neurologist at Harvard-affiliated Brigham and Women’s Hospital in Boston, said it’s important to realize that this is not a cure, just possibly a slowing of decline.
“We’re not suddenly returning people back to their pre-Alzheimer’s baseline,” she said.
Dr. Lynn Kramer, chief medical officer of Eisai’s neurology unit, said the companies would talk with regulators about further studies.
Shares of Biogen, based in Cambridge, Massachusetts, and Eisai, based in Tokyo, soared after July 5 when they announced that the drug had slowed the progression of early Alzheimer’s disease for certain patients. Biogen’s stock jumped 19.6 percent in one day, its biggest move in 14 years, and has continued to rise. Eisai rocketed 40 percent in two days.
Biogen stock gyrated in aftermarket trading after the study results were released. After switching between gains and losses several times, it fell 6.5 percent.

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

These Fresno First-Graders Are Topping Their Peers in Reading

DON'T MISS

Fresno Burial Ceremony to Honor Five Abandoned Babies Set for Saturday

DON'T MISS

Visalia Man Arrested for Soliciting Sex From Minor in Kingsburg

DON'T MISS

Camalah Saleh Cruises to Win in Stormy Fresno State Student Elections

DON'T MISS

Trump Goes Golfing While Stock Market Chunks

DON'T MISS

Brandon Vang Wins Fresno City Council Special Election Outright

DON'T MISS

Trump Says He’s Giving TikTok Another 75 Days to Find a US Buyer

DON'T MISS

Tulare County Man Arrested After Firing at Deputies During Eviction Attempt

DON'T MISS

If ex-Bitwise CEOs Behave in Prison, How Much Less Time Will They Serve?

DON'T MISS

Trump Just Bet the Farm

UP NEXT

USC’s JuJu Watkins Named AP Player of the Year After Historic Sophomore Season

UP NEXT

Dodgers’ Freddie Freeman Lands on Injured List Following Fall in His Shower at Home

UP NEXT

How Trump’s Latest Tariffs Could Affect Your Wallet

UP NEXT

Curry Scores 37 Points and Warriors Beat Lakers in a Potential First-Round Playoff Preview

UP NEXT

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

UP NEXT

Startup Offers Controversial Microplastic Blood Cleansing Treatment

UP NEXT

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

UP NEXT

Flores Homers, Matos and Wade Also Go Deep to Help Giants Cap Sweep of Astros

UP NEXT

Trump Proposes Tax Deduction for Auto Loan Interest on US-Made Cars

UP NEXT

Western US Sees Sharp Increase in Extreme Weather Impact

Bill McEwen,
News Director
Bill McEwen is news director and columnist for GV Wire. He joined GV Wire in August 2017 after 37 years at The Fresno Bee. With The Bee, he served as Opinion Editor, City Hall reporter, Metro columnist, sports columnist and sports editor through the years. His work has been frequently honored by the California Newspapers Publishers Association, including authoring first-place editorials in 2015 and 2016. Bill and his wife, Karen, are proud parents of two adult sons, and they have two grandsons. You can contact Bill at 559-492-4031 or at Send an Email

Camalah Saleh Cruises to Win in Stormy Fresno State Student Elections

3 hours ago

Trump Goes Golfing While Stock Market Chunks

3 hours ago

Brandon Vang Wins Fresno City Council Special Election Outright

3 hours ago

Trump Says He’s Giving TikTok Another 75 Days to Find a US Buyer

4 hours ago

Tulare County Man Arrested After Firing at Deputies During Eviction Attempt

5 hours ago

If ex-Bitwise CEOs Behave in Prison, How Much Less Time Will They Serve?

5 hours ago

Trump Just Bet the Farm

5 hours ago

Staged Crashes and Insurance Fraud: Is Your California Commute a Target?

5 hours ago

Fight Over Phonics: Will CA Require the ‘Science of Reading’ in K-12 Schools?

6 hours ago

Russia Says Trump’s Threats Against Iran Could Trigger ‘Global Catastrophe’

6 hours ago

These Fresno First-Graders Are Topping Their Peers in Reading

Fresno Unified School District has been on the hunt for ways to help bootstrap its youngest students struggling with reading and phonics, an...

1 hour ago

1 hour ago

These Fresno First-Graders Are Topping Their Peers in Reading

A public burial ceremony will be held Saturday, April 5, 2025, in Fresno to honor five abandoned infants, organized by Garden of Innocence – Fresno County. (Garden of Innocence)
1 hour ago

Fresno Burial Ceremony to Honor Five Abandoned Babies Set for Saturday

Uriel Alcala Rios, 25, was arrested for soliciting sex from a 14-year-old girl on Thursday, March 27, 2025. (Kingsburg PD)
2 hours ago

Visalia Man Arrested for Soliciting Sex From Minor in Kingsburg

3 hours ago

Camalah Saleh Cruises to Win in Stormy Fresno State Student Elections

President Donald Trump waves as he arrives at the Trump International Golf Club, Friday, April 4, 2025, in West Palm Beach, Fla. (AP/Alex Brandon)
3 hours ago

Trump Goes Golfing While Stock Market Chunks

3 hours ago

Brandon Vang Wins Fresno City Council Special Election Outright

4 hours ago

Trump Says He’s Giving TikTok Another 75 Days to Find a US Buyer

Kenneth Bratton, 43, was arrested after allegedly firing at Tulare County Sheriff’s deputies during an eviction attempt in Porterville. (Tulare County SO)
5 hours ago

Tulare County Man Arrested After Firing at Deputies During Eviction Attempt

Help continue the work that gets you the news that matters most.

Search

Send this to a friend